Headquarters
1004 BROOKS LN, DELRAY BEACH, FL 33483-6508, US
DELRAY BEACH, FL, US
EPIGENETIX, INC.
From the company
Epigenetix Inc. designs epigenetic drugs; its first drug, EP31670 (NEO2734), is a first-in-class oral once daily dual BRD4 and p300/CBP inhibitor in clinical trials (late stage 1) focused on myelofibrosis and other cancers. Clinical trials are ongoing at the University of Miami (Sylvester), MD Anderson Cancer Center, Mayo Clinic, Dana-Farber Cancer Institute, and the University of Washington/Fred Hutchinson Cancer Research Center.
Products & services offered
Capabilities 3
Facilities
Send your requirements
Quantities, certifications, and timing.